Correlation Between Monopar Therapeutics and Scholar Rock

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Scholar Rock at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Scholar Rock into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Scholar Rock Holding, you can compare the effects of market volatilities on Monopar Therapeutics and Scholar Rock and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Scholar Rock. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Scholar Rock.

Diversification Opportunities for Monopar Therapeutics and Scholar Rock

0.7
  Correlation Coefficient

Poor diversification

The 3 months correlation between Monopar and Scholar is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Scholar Rock Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scholar Rock Holding and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Scholar Rock. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scholar Rock Holding has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Scholar Rock go up and down completely randomly.

Pair Corralation between Monopar Therapeutics and Scholar Rock

Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 1.72 times more return on investment than Scholar Rock. However, Monopar Therapeutics is 1.72 times more volatile than Scholar Rock Holding. It trades about 0.08 of its potential returns per unit of risk. Scholar Rock Holding is currently generating about 0.06 per unit of risk. If you would invest  202.00  in Monopar Therapeutics on September 1, 2024 and sell it today you would earn a total of  2,051  from holding Monopar Therapeutics or generate 1015.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Monopar Therapeutics  vs.  Scholar Rock Holding

 Performance 
       Timeline  
Monopar Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Monopar Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Monopar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.
Scholar Rock Holding 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Scholar Rock Holding are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak basic indicators, Scholar Rock disclosed solid returns over the last few months and may actually be approaching a breakup point.

Monopar Therapeutics and Scholar Rock Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Monopar Therapeutics and Scholar Rock

The main advantage of trading using opposite Monopar Therapeutics and Scholar Rock positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Scholar Rock can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scholar Rock will offset losses from the drop in Scholar Rock's long position.
The idea behind Monopar Therapeutics and Scholar Rock Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world